Statistics

Total Visits

Views
NeoHx study: Perioperative treatment with trastuzumab in combination with capecitabine and oxaliplatin (XELOX-T) in patients with HER2 resectable stomach or esophagogastric junction (EGJ) adenocarcinoma-R0 resection, pCR, and toxicity analysis29

Select a period of time:

Number of views in the range

Views
NeoHx study: Perioperative treatment with trastuzumab in combination with capecitabine and oxaliplatin (XELOX-T) in patients with HER2 resectable stomach or esophagogastric junction (EGJ) adenocarcinoma-R0 resection, pCR, and toxicity analysis16

Views

Views
October 20240
November 20241
December 20240
January 20250
February 20251
March 202514
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore14
United Kingdom1
United States1
 

Top cities views

Views